Publisher
Springer International Publishing
Reference42 articles.
1. Abbas, U. L., Glaubius, R., Mubayi, A., Hood, G., & Mellors, J. W. (2013). Antiretroviral therapy and pre-exposure prophylaxis: Combined impact on HIV transmission and drug resistance in South Africa. Journal of Infectious Diseases, 208(2), 224–234.
2. Amico, K. R., Mansoor, L. E., Corneli, A., Torjesent, K., & van der Straten, A. (2013). Adherence support approaches in biomedical prevention trials: Experiences, insights and future directions from four multisite prevention trials. AIDS Behaviour, 17, 2143–2155.
3. AVAC. (2019). On going and planned PrEP open label demonstration and implementation projects. Retrieved March 25, 2020, from https://www.avac.org/sites/default/files/resource-files/ongoing_planned_oralPrEP_studies_april2019.pdf
4. Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410.
5. Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., et al. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): A randomised, doubleblind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献